Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
Latrofa F, Ricci D, Montanelli L, Rocchi R, Piaggi P, Sisti E, Grasso L, Basolo F, Ugolini C, Pinchera A, Vitti P. Latrofa F, et al. Among authors: rocchi r. J Clin Endocrinol Metab. 2012 Jul;97(7):2380-7. doi: 10.1210/jc.2011-2812. Epub 2012 Apr 26. J Clin Endocrinol Metab. 2012. PMID: 22539585
Surgical treatment of Graves' disease: subtotal or total thyroidectomy?
Miccoli P, Vitti P, Rago T, Iacconi P, Bartalena L, Bogazzi F, Fiore E, Valeriano R, Chiovato L, Rocchi R, Pinchera A. Miccoli P, et al. Among authors: rocchi r. Surgery. 1996 Dec;120(6):1020-4; discussion 1024-5. doi: 10.1016/s0039-6060(96)80049-3. Surgery. 1996. PMID: 8957489
Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.
Chiovato L, Fiore E, Vitti P, Rocchi R, Rago T, Dokic D, Latrofa F, Mammoli C, Lippi F, Ceccarelli C, Pinchera A. Chiovato L, et al. Among authors: rocchi r. J Clin Endocrinol Metab. 1998 Jan;83(1):40-6. doi: 10.1210/jcem.83.1.4492. J Clin Endocrinol Metab. 1998. PMID: 9435414
Graves' ophthalmopathy and 131I therapy.
Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Mazzi B, Rocchi R, Barbesino G, Pinchera A. Marcocci C, et al. Among authors: rocchi r. Q J Nucl Med. 1999 Dec;43(4):307-12. Q J Nucl Med. 1999. PMID: 10731781 Review.
Soluble interleukin-1 receptor antagonist concentration in patients with Graves' ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoids.
Bartalena L, Manetti L, Tanda ML, Dell'Unto E, Mazzi B, Rocchi R, Barbesino G, Pinchera A, Marcocci C. Bartalena L, et al. Among authors: rocchi r. Clin Endocrinol (Oxf). 2000 May;52(5):647-51. doi: 10.1046/j.1365-2265.2000.00988.x. Clin Endocrinol (Oxf). 2000. PMID: 10792346
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartei F, Nardi M, Pinchera A. Marcocci C, et al. Among authors: rocchi r. J Clin Endocrinol Metab. 2001 Aug;86(8):3562-7. doi: 10.1210/jcem.86.8.7737. J Clin Endocrinol Metab. 2001. PMID: 11502779 Clinical Trial.
212 results